BRAF V600E 突变转移性黑色素瘤中的线粒体功能障碍与免疫抑制 - Suppr

Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.

作者信息

Pinto de Almeida Natália, Jánosi Ágnes Judit, Hong Runyu, Rajeh Ahmad, Nogueira Fábio, Szadai Leticia, Szeitz Beata, Pla Parada Indira, Doma Viktória, Woldmar Nicole, Guedes Jéssica, Újfaludi Zsuzsanna, Bartha Aron, Kim Yonghyo, Welinder Charlotte, Baldetorp Bo, Kemény Lajos Vince, Pahi Zoltan, Wan Guihong, Nguyen Nga, Pankotai Tibor, Győrffy Balázs, Pawłowski Krzysztof, Horvatovich Peter, Szasz Attila Marcell, Sanchez Aniel, Kuras Magdalena, Rodriguez Murillo Jimmy, Betancourt Lazaro, Domont Gilberto B, Semenov Yevgeniy R, Yu Kun-Hsing, Kwon Ho Jeong, Németh István Balázs, Fenyő David, Wieslander Elisabet, Marko-Varga György, Gil Jeovanis

机构信息

Laboratory of Proteomics/LADETEC, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.

Proteomics Unit, Institute of Chemistry, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Clin Transl Med. 2024 Jul;14(7):e1773. doi: 10.1002/ctm2.1773.

DOI:10.1002/ctm2.1773

PMID:39032005

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11259597/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282e/11259597/df1370cd4f87/CTM2-14-e1773-g004.jpg

相似文献

Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.BRAF V600E 突变转移性黑色素瘤中的线粒体功能障碍与免疫抑制

Clin Transl Med. 2024 Jul;14(7):e1773. doi: 10.1002/ctm2.1773.

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.自然杀伤细胞对于 BRAF 抑制剂控制 BRAFV600E 突变转移性黑色素瘤的能力至关重要。

Cancer Res. 2014 Dec 15;74(24):7298-308. doi: 10.1158/0008-5472.CAN-14-1339. Epub 2014 Oct 28.

Analysis of BRAF mutation in primary and metastatic melanoma.原发性和转移性黑色素瘤中BRAF突变的分析

Cell Cycle. 2005 Oct;4(10):1382-4. doi: 10.4161/cc.4.10.2026. Epub 2005 Oct 13.

Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in Mutant Melanoma.融合作为一种新型机制，可导致突变型黑色素瘤对威罗菲尼产生获得性耐药。

Clin Cancer Res. 2017 Sep 15;23(18):5631-5638. doi: 10.1158/1078-0432.CCR-16-0758. Epub 2017 May 24.

Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma.肠道微生物群和免疫基因表达与BRAF突变型黑色素瘤靶向治疗反应的关联

Sci Rep. 2025 Jul 14;15(1):25430. doi: 10.1038/s41598-025-11054-2.

Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.免疫细胞化学在检测转移性黑色素瘤患者循环肿瘤细胞中BRAF（V600E）突变的应用价值。

J Invest Dermatol. 2013 May;133(5):1378-81. doi: 10.1038/jid.2012.485. Epub 2013 Jan 10.

BRAF V600E-dependent role of autophagy in uveal melanoma.自噬在葡萄膜黑色素瘤中依赖BRAF V600E的作用

J Cancer Res Clin Oncol. 2017 Mar;143(3):447-455. doi: 10.1007/s00432-016-2317-y. Epub 2016 Dec 7.

Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.原发性黑色素瘤及配对转移灶中BRAFV600突变的等位基因频率及其与转移性黑色素瘤BRAF抑制剂治疗的相关性。

Oncotarget. 2015 Nov 10;6(35):37895-905. doi: 10.18632/oncotarget.5634.

Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.比较配对的原发性和转移性皮肤黑色素瘤中的BRAF突变状态：对优化靶向治疗的意义。

Exp Mol Pathol. 2014 Dec;97(3):315-20. doi: 10.1016/j.yexmp.2014.09.008. Epub 2014 Sep 16.

Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients.与BRAF野生型黑色素瘤患者相比，BRAF突变型黑色素瘤患者首次转移时年龄更小。

Oncol Rep. 2014 Aug;32(2):808-14. doi: 10.3892/or.2014.3265. Epub 2014 Jun 13.

引用本文的文献

Nutrition and Diet Patterns as Key Modulators of Metabolic Reprogramming in Melanoma Immunotherapy.营养与饮食模式作为黑色素瘤免疫治疗中代谢重编程的关键调节因素

J Clin Med. 2025 Jun 12;14(12):4193. doi: 10.3390/jcm14124193.

Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.线粒体蛋白质组全景揭示了黑色素瘤严重程度和治疗策略的关键见解。

Cancer. 2025 Jul 1;131(13):e35897. doi: 10.1002/cncr.35897.

本文引用的文献

Protein neddylation and its role in health and diseases.蛋白质的类泛素化及其在健康和疾病中的作用。

Signal Transduct Target Ther. 2024 Apr 5;9(1):85. doi: 10.1038/s41392-024-01800-9.

Mitochondrial and immune response dysregulation in melanoma recurrence.黑色素瘤复发中的线粒体与免疫反应失调

Clin Transl Med. 2023 Nov;13(11):e1495. doi: 10.1002/ctm2.1495.

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.黑色素瘤中的BRAF突变：生物学特性、治疗意义及循环生物标志物

Cancers (Basel). 2023 Aug 8;15(16):4026. doi: 10.3390/cancers15164026.

Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression.线粒体分裂通过降低 MHC-I 表面表达在实体瘤中诱导免疫逃逸。

Nat Commun. 2022 Jul 6;13(1):3882. doi: 10.1038/s41467-022-31417-x.

The Interplay between Cell-Extracellular Matrix Interaction and Mitochondria Dynamics in Cancer.癌症中细胞与细胞外基质相互作用和线粒体动力学之间的相互作用

Cancers (Basel). 2022 Mar 10;14(6):1433. doi: 10.3390/cancers14061433.

An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation.一项关于原发性黑色素瘤分子图谱的观察性研究揭示了其进展对线粒体激活的依赖性。

Cancers (Basel). 2021 Dec 1;13(23):6066. doi: 10.3390/cancers13236066.

The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome.人类黑色素瘤蛋白质组图谱-补充黑色素瘤转录组。

Clin Transl Med. 2021 Jul;11(7):e451. doi: 10.1002/ctm2.451.

BRAF V600E mutational load as a prognosis biomarker in malignant melanoma.BRAF V600E 突变负荷作为恶性黑色素瘤的预后生物标志物。

PLoS One. 2020 Mar 13;15(3):e0230136. doi: 10.1371/journal.pone.0230136. eCollection 2020.

Melanoma proteomics suggests functional differences related to mutational status.黑色素瘤蛋白质组学提示与突变状态相关的功能差异。

Sci Rep. 2019 May 10;9(1):7217. doi: 10.1038/s41598-019-43512-z.

Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.苯乙双胍增强 BRAF(V600E) 抑制在黑色素瘤中的治疗获益。

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18226-31. doi: 10.1073/pnas.1317577110. Epub 2013 Oct 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献